4118.T

Kaneka Corporation [4118.T] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

4118.T Stock Summary

Earnings have grown 9.3% per last year.

Earnings are expected to fall -100% next year

Profit margins (0.02%) are lower than the previous year (0.03%)

4118.T has less than 1 year of cash runway

Top 10 Correlated ETFs

4118.T

Top 10 Correlated Stocks

4118.T

In the News

4118.T Financial details

Company Rating

Buy

Market Cap

253.61B

Income

17.56B

Revenue

753.41B

Book val./share

6713.91

Cash/share

699.91

Dividend

110

Dividend %

3.05%

Employees

11.55K

Optionable

Shortable

Yes

Earnings

10 May 2024

P/E

15.46

Forward P/E

PEG

-4.61

P/S

0.31

P/B

0.54

P/C

5.56

P/FCF

Quick Ratio

0.77

Current Ratio

1.42

Debt / Equity

0.42

LT Debt / Equity

0.12

EPS (TTM)

269.87

EPS next Y

EPS next Q

EPS this Y

-13.89%

EPS next Y

EPS next 5Y

EPS last 5Y

0.61%

Revenue last 5Y

4.01%

Revenue Q/Q

3.86%

EPS Q/Q

-2.48%

SMA20

4.53%

SMA50

10.34%

SMA100

4.17%

Inst Own

Inst Trans

ROA

ROE

ROC

0.05%

Gross Margin

26%

Oper. Margin

Profit Margin

Payout

Shs Outstand

Shs Float

Target Price

52W Range

3456.0-4288.0

52W High

-9.28%

52W Low

+12.56%

RSI

Rel Volume

0.84

Avg Volume

220.64K

Volume

184.9K

Perf Week

-1.29%

Perf Month

5.45%

Perf Quarter

4.54%

Perf Half Y

3.18%

Beta

0.612

Volatility

47.56%, 90.63%

Prev Close

-1.27%

Price

3890

Change

-1.12%

4118.T Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-03-31

Metric	2019-03-31	2020-03-31	2021-03-31	2022-03-31	2023-03-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	9.47K	9.22K	8.85K	10.6K	11.48K
Net income per share	339.14	214.69	242.68	406	349.59
Operating cash flow per share	627	613.01	1.14K	522.79	436.22
Free cash flow per share	-71.42	-96.45	485.09	-89.27	-201.79
Cash per share	627.37	596.99	734.61	643.05	636.15
Book value per share	5.15K	5.09K	5.48K	5.94K	6.35K
Tangible book value per share	5.3K	5.23K	5.63K	6.09K	6.39K
Share holders equity per share	5.15K	5.09K	5.48K	5.94K	6.35K
Interest debt per share	1.9K	2.05K	1.85K	1.99K	2.7K
Market cap	280.64B	168.93B	296.81B	231.27B	227.06B
Enterprise value	362.53B	262.31B	368.44B	318.16B	361.23B
P/E ratio	12.62	12.06	18.75	8.73	9.87
Price to sales ratio	0.45	0.28	0.51	0.33	0.3
POCF ratio	6.83	4.23	4.01	6.78	7.91
PFCF ratio	-59.93	-26.85	9.38	-39.71	-17.1
P/B Ratio	0.83	0.51	0.83	0.6	0.54
PTB ratio	0.83	0.51	0.83	0.6	0.54
EV to sales	0.58	0.44	0.64	0.46	0.48
Enterprise value over EBITDA	5.4	4.49	5.94	3.91	4.7
EV to operating cash flow	8.82	6.56	4.98	9.33	12.58
EV to free cash flow	-77.41	-41.7	11.64	-54.63	-27.2
Earnings yield	0.08	0.08	0.05	0.11	0.1
Free cash flow yield	-0.02	-0.04	0.11	-0.03	-0.06
Debt to equity	0.36	0.4	0.33	0.33	0.42
Debt to assets	0.19	0.2	0.18	0.18	0.22
Net debt to EBITDA	1.22	1.6	1.16	1.07	1.75
Current ratio	1.47	1.45	1.46	1.55	1.54
Interest coverage	17.9	15.18	21.88	40.94	17.86
Income quality	1.29	2.02	3.33	0.94	0.89
Dividend Yield	0.02	0.04	0.02	0.03	0.03
Payout ratio	0.27	0.49	0.41	0.25	0.33
Sales general and administrative to revenue	0.11	0.12	0.12	0.11	0.11
Research and developement to revenue	0.05	0.05	0.05	0.04	0.04
Intangibles to total assets	0.02	0.02	0.02	0.02	0.02
Capex to operating cash flow	-1.11	-1.16	-0.57	-1.17	-1.46
Capex to revenue	-0.07	-0.08	-0.07	-0.06	-0.06
Capex to depreciation	-1.42	-1.35	-1.17	-1.05	-1.06
Stock based compensation to revenue	0	0	0	0	0
Graham number	6.27K	4.96K	5.47K	7.37K	7.07K
ROIC	0.06	0.04	0.04	0.06	0.04
Return on tangible assets	0.03	0.02	0.02	0.04	0.03
Graham Net	-1.38K	-1.55K	-1.26K	-1.22K	-1.41K
Working capital	100.33B	95.26B	96.72B	128.41B	138.72B
Tangible asset value	347.3B	340.91B	367.21B	397.23B	420.23B
Net current asset value	15.38B	7.69B	22.63B	48.15B	50.74B
Invested capital	0.36	0.4	0.33	0.33	0.42
Average receivables	147.91B	141.05B	134.86B	149.87B	167.14B
Average payables	84.86B	79.15B	74.63B	83.91B	90.37B
Average inventory	108.32B	114.85B	113.47B	125.08B	154.3B
Days sales outstanding	86.98	81.38	85.73	86.63	82.17
Days payables outstanding	69.36	62.05	67.36	67.9	58.11
Days of inventory on hand	91.96	98.99	97.53	103.61	110.19
Receivables turnover	4.2	4.49	4.26	4.21	4.44
Payables turnover	5.26	5.88	5.42	5.38	6.28
Inventory turnover	3.97	3.69	3.74	3.52	3.31
ROE	0.07	0.04	0.04	0.07	0.06
Capex per share	-698.42	-709.46	-649.92	-612.06	-638.02

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q3

Metric	2022-12-31	2023-03-31	2023-06-30	2023-09-30	2023-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	2.8K	2.88K	2.82K	2.89K	3K
Net income per share	34.87	62.84	65.35	71.73	69.95
Operating cash flow per share	301.31	306.72	311.49	312.97	315.16
Free cash flow per share	301.31	306.72	311.49	312.97	315.16
Cash per share	568.91	638.9	577.81	733.37	699.91
Book value per share	6.14K	6.38K	6.63K	6.74K	6.71K
Tangible book value per share	6.19K	6.41K	6.68K	6.79K	6.73K
Share holders equity per share	6.14K	6.38K	6.63K	6.74K	6.71K
Interest debt per share	2.34K	2.69K	2.67K	2.77K	2.8K
Market cap	219.08B	226.08B	260.96B	252B	232.52B
Enterprise value	336.54B	360.25B	395.85B	384.5B	368.25B
P/E ratio	23.59	13.73	15.38	13.53	12.8
Price to sales ratio	1.17	1.2	1.43	1.34	1.19
POCF ratio	10.92	11.25	12.91	12.4	11.37
PFCF ratio	10.92	11.25	12.91	12.4	11.37
P/B Ratio	0.54	0.54	0.61	0.58	0.53
PTB ratio	0.54	0.54	0.61	0.58	0.53
EV to sales	1.8	1.91	2.17	2.05	1.89
Enterprise value over EBITDA	65.7	43.51	51.36	53.22	19.15
EV to operating cash flow	16.77	17.92	19.58	18.93	18
EV to free cash flow	16.77	17.92	19.58	18.93	18
Earnings yield	0.01	0.02	0.02	0.02	0.02
Free cash flow yield	0.09	0.09	0.08	0.08	0.09
Debt to equity	0.38	0.42	0.4	0.41	0.42
Debt to assets	0.2	0.22	0.21	0.21	0.21
Net debt to EBITDA	22.93	16.2	17.5	18.34	7.06
Current ratio	1.49	1.54	1.49	1.42	1.45
Interest coverage	11.56	11.93	7.47	8.24	10.28
Income quality	8.64	4.88	4.77	4.36	4.51
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0	-0.06	0	0	0
Research and developement to revenue	0.04	0.04	0.05	0.05	0.04
Intangibles to total assets	0.02	0.02	0.02	0.02	0.02
Capex to operating cash flow	0	0	0	0	0
Capex to revenue	0	0	0	0	0
Capex to depreciation	0	0	0	0	0
Stock based compensation to revenue	0	0	0	0	0
Graham number	2.2K	3K	3.12K	3.3K	3.25K
ROIC	0.01	0.01	0.01	0.01	0.01
Return on tangible assets	0	0.01	0.01	0.01	0.01
Graham Net	-1.6K	-1.41K	-1.74K	-1.69K	-1.97K
Working capital	131.92B	138.72B	133.86B	126.45B	131.18B
Tangible asset value	411.9B	420.23B	433.25B	440.67B	436.93B
Net current asset value	41.52B	50.74B	41.79B	41.48B	30.52B
Invested capital	0.38	0.42	0.4	0.41	0.42
Average receivables	172.84B	172.93B	169.27B	175.94B	180.95B
Average payables	96.64B	94.57B	89.77B	94.56B	101.44B
Average inventory	168.84B	169.44B	173.96B	179.07B	177.14B
Days sales outstanding	84.77	81.16	82.93	88.13	82.5
Days payables outstanding	65.11	56.7	59.98	64.24	66.17
Days of inventory on hand	110.66	107.51	118.69	116.59	111.29
Receivables turnover	1.06	1.11	1.09	1.02	1.09
Payables turnover	1.38	1.59	1.5	1.4	1.36
Inventory turnover	0.81	0.84	0.76	0.77	0.81
ROE	0.01	0.01	0.01	0.01	0.01
Capex per share	0	0	0	0	0

4118.T Dividend History

4118.T Frequently Asked Questions

What is Kaneka Corporation stock symbol ?

Kaneka Corporation is a JP stock and trading under the symbol 4118.T

What is Kaneka Corporation stock quote today ?

Kaneka Corporation stock price is $3890 today.

Is Kaneka Corporation stock public?

Yes, Kaneka Corporation is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 220.64K
Market Capitalization 253.61B
Employee 11.55K
CEO Mr. Minoru Tanaka
Headquarters Tokyo,JP
IPO Date 2001-01-01
Website https://www.kaneka.co.jp

Kaneka Corporation manufactures and sells polyvinyl chloride (PVC), crosslinked PVC, PVC-PVAc polymers, paste PVC, acryl grafted-vinyl chloride copolymer, and chlorinated PVC in Japan and internationally. It provides impact modifiers, processing aids, specialty additives, toughener for thermosetting resins, silyl-terminated polyether, acrylic silicon, terminally reactive liquid acrylic, and biodegradable polymer, engineering resin for injection molding, zero birefringence, acrylic film, and isobutylene-based thermoplastic elastomer products. The company also offers polypropylene and kanelite foams, extruded polystyrene foam insulation, polyimide film, transparent film for optical use, high thermal conductive graphite sheets, multi-layer insulation, transparent conductive film, and thermo-resistant, and light-resistant transparent resin products. In addition, it provides photovoltaic power generation systems for residences, public, and industrial installations; eco fur, flame-retardant, hair accessory, and new materials; organic EL lighting panels; and biosurfactant. Further, the company offers intervention, blood purification, gastroenterology intervention, testing equipment, regenerative medicine and cell therapy, and genetic diagnostic products; and low molecular pharmaceutical materials, affinity chromatography resin for purification of a monoclonal antibody, biopharmaceuticals, transdermal medicine, and innerwear with shock-absorbing pad. It also provides dairy products, margarine, fat and oils, whipping cream, filling, baker's yeast/ dough improver, processed fruits, butter, shortening, cacao butter alternatives, cream for kneading and other uses, frozen dough, spices, antifreeze materials; and pharma and supplemental nutrition solutions, including coenzyme, lactic-acid bacteria, and functional foodstuffs, as well as fertilizers. Kaneka Corporation was incorporated in 1949 and is headquartered in Tokyo, Japan.